美国食品药品监督管理局(FDA)拒绝批准百时美施贵宝公司(PTC Therapeutics)治疗罕见遗传病的药物后该公司

智通财经
Aug 19
美国食品药品监督管理局(FDA)拒绝批准百时美施贵宝公司(PTC Therapeutics)治疗罕见遗传病的药物后该公司股价在盘前交易中下跌5.6% 。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10